insulin pump risks and benefits a clinical appraisal of pump.pdfVIP

Diabetologia DOI 10.1007/s00125-015-3513-z ARTICLE Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group Lutz Heinemann G. Alexander Fleming John R. Petrie Reinhard W. Holl Richard M. Bergenstal Anne L. Peters Received: 24 December 2014 /Accepted: 30 December 2014 # Springer-Verlag Berlin Heidelberg 2015 Abstract Insulin pump therapy, also known as continuous sulin pumps, errors of insulin infusion can occur due to pump subcutaneous insulin infusion (CSII), is an important and failure, insulin infusion set (IIS) blockage, infusion site prob- evolving form of insulin delivery, which is mainly used for lems, insulin stability issues, user error or a combination of people with type 1 diabetes. However, even with modern in- these. Users are therefore exposed to significant and potential- ly fatal hazards: interruption of insulin infusion can result in hyperglycaemia and ketoacidosis; conversely, delivery of ex- cessive insulin can cause severe hypoglycaemia. Neverthe- Simultaneous publication This article is being simultaneously less, the available evidence on the safety and efficacy of CSII published in Diabetes Care and Diabetologia by the American Diabetes remains limited. The European Association for the Study of Association and the European Association for the Study of Diabetes. Diabetes (EASD) and American Diabetes Association (ADA) Copyright 2